Main navigation
Here you will find a range of information relating to our corporate governance.
We apply the main and supporting principles of good governance in the UK Combined Code on Corporate Governance published in July 2003 by the Financial Reporting Council, as amended in June 2006.
As a foreign issuer with American Depositary Shares listed on the New York Stock Exchange (NYSE), we must also disclose any significant ways in which our corporate governance practices differ from those followed by US companies under the NYSE’s corporate governance listing standards.
Detailed information concerning our performance in regard to corporate governance, during each financial year, can be found in our Annual Reports.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 20-Nov-2009 23:01 GMT
Detailed share priceStock symbol - AZN
On LSE, NYSE and OMX
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
